COMMUNIQUÉS West-GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027 Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-label [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2026
BRISBANE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026
This first-in-class differentiated approach will be highlighted during a Featured Research Session entitled Alzheimer's therapy: mechanisms beyond amyloid ROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc [...]
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08/07/2026
The appointment follows New c elX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101 , providing a clear regulatory pathway toward clinical trials Dr. Ricordi to s upport a dvancement of New c elX's [...]
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
08/07/2026
Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “ [...]
SRX Global Declares One-Time Cash Dividend
08/07/2026
Company delivering $1 million in aggregate to shareholders via cash dividend payment from profits related to investment in SpaceX and hedging strategies NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX [...]
Families Report Positive Outcomes From Fully Virtual, BCBA-Delivered, Focused Autism Support Program
08/07/2026
Study finds that fully virtual applied behavior analysis therapy conducted by BCBA clinicians at AnswersNow for autism support is feasible, well received by caregivers, and linked to positive outcomes for children and [...]
Global Alzheimer’s Platform Foundation Announces Strategic Partnership with Taudia for the Transformative Bio-Hermes-002 Study
08/07/2026
Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON. D.C., July 08, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform [...]
Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments
08/07/2026
July 8, 2026 Newest addition to the Philips ultrasound portfolio, Alturion recently received FDA 510(k) clearance and CE mark, expanding access to advanced imaging and workflow innovation across clinical settings [...]
GumiTide Official Announces 2026 In The USA & Canada New Advanced Formula Gumitide Gummies For Weight Loss in Markets
08/07/2026
Discover Gumitide Gummies, a natural dietary supplement designed to support metabolism, appetite control, and healthy weight management. Made in the USA with quality ingredients like apple cider vinegar and BHB mineral [...]
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
08/07/2026
Retrospective fragmentomics capability lets biopharma and academic researchers extract a second dimension of biology from archived liquid biopsy DNA sequencing data DURHAM, N.C., July 08, 2026 (GLOBE NEWSWIRE) -- [...]
Cerene® Cryotherapy Announces Know Your Flow Event Series To Empower Women Through Free Menstrual and Perimenopause Education
08/07/2026
The First Two Events Will Take Place in New York and Charlotte BERKELEY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems’ Cerene® Cryotherapy is proud to announce the launch of its Know Your Flow Event [...]
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026
MADISON, Wis., July 08, 2026 (GLOBE NEWSWIRE) -- Nordic ® , a global health and technology consulting company, has been ranked No. 1 overall in Black Book Market Research's 2026 Healthcare IT Consulting & Advisory [...]
Cannara Biotech Inc. annoncera ses résultats financiers pour le troisième trimestre de l'exercice 2026 le 15 juillet 2026
08/07/2026
MONTRÉAL, 08 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de cannabis [...]
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
08/07/2026
License expands collaboration with Florida State University to evaluate castanospermine for Powassan virus disease, tick-borne encephalitis, alpha-gal syndrome, and post-treatment Lyme disease Agreement builds on [...]
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
08/07/2026
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days of Patent Term Adjustment Notice of allowance also received in a [...]
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
08/07/2026
RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel [...]
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. VANCOUVER, British Columbia, July 08, 2026 (GLOBE NEWSWIRE) -- Cannabix [...]

Pages